-+ 0.00%
-+ 0.00%
-+ 0.00%

*NextCure: LNCB74 Phase 1 Dose Escalation Trial Update Planned in 2H of 2026 >NXTC

Dow Jones·03/05/2026 21:10:00

Please log in to view news